Abstract
The paper considers the new gout classification criteria approved by the Board of Directors of the American College of Rheumatology (ACR) and the Executive Committee of the European League Against Rheumatism (EULAR). The criteria have been elaborated on the basis of quantitative assessment of the data obtained during the examinations of patients and have high sensitivity (92%) and specificity (89%). These classification criteria will be able to standardize an approach to making up relatively homogeneous groups of patients having the clinical signs of gout to be enrolled into the investigation.
Highlights
Рассмотрены новые классификационые критерии подагры, утвержденные Советом директоров Американской коллегии ревматологов (АCR) и Исполнительным комитетом Европейской антиревматической лиги (EULAR)
The paper considers the new gout classification criteria approved by the Board of Directors of the American College of Rheumatology (ACR) and the Executive Committee of the European League Against Rheumatism (EULAR)
The criteria have been elaborated on the basis of quantitative assessment of the data obtained during the examinations of patients and have high sensitivity (92%) and specificity (89%). These classification criteria will be able to standardize an approach to making up relatively homogeneous groups of patients having the clinical signs of gout to be enrolled into the investigation
Summary
Рассмотрены новые классификационые критерии подагры, утвержденные Советом директоров Американской коллегии ревматологов (АCR) и Исполнительным комитетом Европейской антиревматической лиги (EULAR). Данные классификационные критерии позволят стандартизировать подход к формированию относительно однородных групп пациентов, имеющих клинические признаки подагры, для включения в исследования.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
